Analytical Data
-
基因名
ugl
- Application
-
别名
ugl；FN；Fibronectin
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9RC92
-
表达区间
1-377aa
-
氨基酸序列
MWQQAIGDALGITARNLKKFGDRFPHVSDGSNKYVLNDNTDWTDGFWSGILWLCYEYTGDEQYREGAVRTVASFRERLDRFENLDHHDIGFLYSLSAKAQWIVEKDESARKLALDAADVLMRRWRADAGIIQAWGPKGDPENGGRIIIDCLLNLPLLLWAGEQTGDPEYRRVAEAHALKSRRFLVRGDDSSYHTFYFDPENGNAIRGGTHQGNTDGSTWTRGQAWGIYGFALNSRYLGNADLLETAKRMARHFLARVPEDGVVYWDFEVPQEPSSYRDSSASAITACGLLEIASQLDESDPERQRFIDAAKTTVTALRDGYAERDDGEAEGFIRRGSYHVRGGISPDDYTIWGDYYYLEALLRLERGVTGYWYERGR
-
分子量
42.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Ugl (Ubiquitin-like protein) recombinant proteins have garnered significant attention in the fields of molecular biology and biotechnology due to their critical roles in cellular processes. These proteins are often involved in the regulation of protein degradation, cell cycle progression, and response to stress, functioning through mechanisms similar to ubiquitin. The study of Ugl recombinant proteins is essential for understanding their structure-function relationships and the pathways they influence, which can have profound implications for disease models, particularly in cancer and neurodegenerative disorders. Advances in techniques such as CRISPR-Cas9 gene editing and recombinant DNA technology have facilitated the expression and purification of Ugl proteins, allowing researchers to investigate their biological activities in detail. Additionally, the therapeutic potential of Ugl proteins is being explored, as manipulating their signaling pathways could lead to novel treatment strategies. Overall, the research on Ugl recombinant proteins not only expands our fundamental knowledge of cellular biology but also opens new avenues for therapeutic development in various diseases.
